Rosemary Harrison

Rosemary Harrison

Corporate Officer/Principal chez TCR2 THERAPEUTICS INC.
43 ans
Health Technology
Commercial Services
Consumer Services

Profil

Rosemary Harrison is currently the Chief Business & Strategy Officer at TCR2 Therapeutics, Inc. She previously worked as the Senior VP-Corporate Development & Strategy at Trillium Therapeutics ULC from 2020 to 2021, Head-Portfolio Management & Strategic Planning at Novartis Institutes for Biomedical Research, Inc. from 2015 to 2018, and Head-Rare Diseases at Imbria Pharmaceuticals, Inc. from 2019 to 2020.
She holds a doctorate degree from The University of Queensland.

Postes actifs de Rosemary Harrison

SociétésPosteDébut
TCR2 THERAPEUTICS INC. Corporate Officer/Principal 01/01/2022

Anciens postes connus de Rosemary Harrison

SociétésPosteFin
TRILLIUM THERAPEUTICS Investor Relations Contact 01/11/2021
Corporate Officer/Principal 01/03/2020
Corporate Officer/Principal 01/05/2018
Voir l'expérience en détail de Rosemary Harrison

Formation de Rosemary Harrison

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

53

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Health Technology

Consumer Services

Commercial Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Rosemary Harrison
🔇